Condition: Efficacy and Safety
Interventions: Biological: IBI308; Biological: paclitaxel/ irinotecan
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting - verified April 2017
http://ift.tt/2ou7LA6
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου